Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 May;15(5):322.
doi: 10.1007/s11894-013-0322-8.

Barrett's esophagus in 2012: updates in pathogenesis, treatment, and surveillance

Subhash Chandra  1 , Emmanuel C Gorospe, Cadman L Leggett, Kenneth K Wang
Affiliations
Review

Barrett's esophagus in 2012: updates in pathogenesis, treatment, and surveillance

Subhash Chandra et al. Curr Gastroenterol Rep. 2013 May.

Abstract

Barrett's esophagus (BE) is the only established precursor lesion in the development of esophageal adenocarcinoma (EAC) and it increases the risk of cancer by 11-fold. It is regarded as a complication of gastroesophageal reflux disease. There is an ever-increasing body of knowledge on the pathogenesis, diagnosis, treatment, and surveillance of BE and its associated dysplasia. In this review, we summarize the latest advances in BE research and clinical practice in the past 2 years. It is critical to understand the molecular underpinnings of this disorder to comprehend the clinical outcomes of the disease. For clinical gastroenterologists, there is also continuous growth of endoscopic approaches which is daunting, and further improvements in the detection and treatment of BE and early EAC are anticipated. In the future, we may see the increased role of biomarkers, both molecular and imaging, in both diagnostic and therapeutic strategies for BE.

PubMed Disclaimer

Conflict of interest statement

DISCLOSURE

No potential conflicts of interest relevant to this article were reported.

References

    1. Wang KK. Endoscopic vs surgical resection for Barrett’s intramucosal adenocarcinoma: beyond a therapeutic equipoise. Gastroenterology. 2012;143(1):257–259. - PubMed
    1. Peters FP, Curvers WL, Rosmolen WD, et al. Surveillance history of endoscopically treated patients with early Barrett’s neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error. Dis Esophagus. 2008;21(6):475–479. - PubMed
    1. Prasad GA, Wang KK, Halling KC, et al. Correlation of histology with biomarker status after photodynamic therapy in Barrett esophagus. Cancer. 2008;113(3):470–476. - PMC - PubMed
    1. Sarosi G, Brown G, Jaiswal K, et al. Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett’s esophagus. Dis Esophagus. 2008;21(1):43–50. - PubMed
    1. Hutchinson L, Stenstrom B, Chen D, et al. Human Barrett’s adenocarcinoma of the esophagus, associated myofibroblasts, and endothelium can arise from bone marrow-derived cells after allogeneic stem cell transplant. Stem cells and development. 2011;20(1):11–17. - PMC - PubMed

Publication types

MeSH terms